Biotech NewsInsmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri BioTech Health XOctober 3, 2025 Insmed Inc. (NASDAQ:INSM) is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and… 0 Shares 0 0 0 0 0 0 0